The Pathogenesis of Acromegaly Complicated with Diabetes Mellitus

Jun ZHONG; Jing-yun FU

doi:10.12259/j.issn.2095-610X.S20210529

Volume 42 Issue 5

May 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2021 > 42(5): 159-164

Jun ZHONG, Jing-yun FU. The Pathogenesis of Acromegaly Complicated with Diabetes Mellitus[J]. Journal of Kunming Medical University, 2021, 42(5): 159-164. doi: 10.12259/j.issn.2095-610X.S20210529

Citation:

Jun ZHONG, Jing-yun FU. The Pathogenesis of Acromegaly Complicated with Diabetes Mellitus[J]. Journal of Kunming Medical University, 2021, 42(5): 159-164. doi: 10.12259/j.issn.2095-610X.S20210529

Jun ZHONG, Jing-yun FU. The Pathogenesis of Acromegaly Complicated with Diabetes Mellitus[J]. Journal of Kunming Medical University, 2021, 42(5): 159-164. doi: 10.12259/j.issn.2095-610X.S20210529

Citation:

Jun ZHONG, Jing-yun FU. The Pathogenesis of Acromegaly Complicated with Diabetes Mellitus[J]. Journal of Kunming Medical University, 2021, 42(5): 159-164. doi: 10.12259/j.issn.2095-610X.S20210529

PDF( 564 KB)

The Pathogenesis of Acromegaly Complicated with Diabetes Mellitus

doi: 10.12259/j.issn.2095-610X.S20210529

Jun ZHONG,
Jing-yun FU^,

Dept.of Endocrinology，The 1st Affiliated Hospital of Kunming Medical University，Kunming Yunnan 650032，China

Received Date: 2021-01-05
Available Online: 2021-06-08
Publish Date: 2021-05-20

Abstract

Abstract

Hypersecretion of GH in acromegaly produces the insulin resistance and is prone to diabetes mellitus.The main mechanism is that the insulin receptor and its substrate phosphorylation level, phosphatidylinositol 3 kinase regulatory subunit P85 level, glucose transport level and 11β-Hydroxysteroid Dehydrogenaseactivity play a series of roles through the growth hormone receptor, resulting in glucose metabolism disorder.
- Acromegaly,
- Growth hormone,
- Diabetes mellitus

FullText(HTML)

References(46)

References

[1]	Silverstein J M. Need for improved monitoring in patients with acromegaly[J]. Endocr Connect,2015,4(4):R59-R67. doi: 10.1530/EC-15-0064
[2]	Vijayakumar R,Wu Y J,Sun H,et al. Targeted loss of GHR signaling in mouse skeletal muscle protects against high-fat diet–induced metabolic deterioration[J]. Diabetes,2012,61(1):94-103. doi: 10.2337/db11-0814
[3]	Katznelson L,Laws E R,Jr,et al. Acromegaly:An endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab,2014,99(11):3933-3951. doi: 10.1210/jc.2014-2700
[4]	Colao A,Ferone D,Marzullo P,et al. Systemic complications of acromegaly:Epidemiology,pathogenesis,and management[J]. Endocr Rev,2004,25(1):102-152. doi: 10.1210/er.2002-0022
[5]	M H I,C R R,D G G. Factors influencing mortality in acromegaly[J]. J Clin Endocrinol Metab,2004,89(2):667-674. doi: 10.1210/jc.2003-031199
[6]	Foss M C,Saad M J,Paccola G M,et al. Peripheral glucose metabolism in acromegaly[J]. J Clin Endocrinol Metab,1991,72(5):1048-1053. doi: 10.1210/jcem-72-5-1048
[7]	Cheng S,Gomez K,Serri O,et al. The role of diabetes in acromegaly associated neoplasia[J]. PLoS One,2015,10(5):e0127276. doi: 10.1371/journal.pone.0127276
[8]	Andersen M. Management of endocrine disease:GH excess:Diagnosis and medicaltherapy[J]. Eur J Endocrinol,2014,170(1):R31-R41. doi: 10.1530/EJE-13-0532
[9]	Bartke A,Sun L Y,Longo V. Somatotropic signaling:Trade-offs between growth,reproductive development,and longevity[J]. Physiol Rev,2013,93(2):571-598. doi: 10.1152/physrev.00006.2012
[10]	Young J A,List E O,Kopchick J J. Deconstructing the growth hormone receptor (GHR):Physical and metabolic phenotypes of tissue-specific GHR gene-disrupted mice[J]. Prog Mol Biol Transl Sci,2016,138(17):27-39.
[11]	Liu J L,Coschigano K T,Robertson K,et al. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice[J]. Am J Physiol Endocrinol Metab,2004,287(3):E405-E413. doi: 10.1152/ajpendo.00423.2003
[12]	Guo Y,Lu Y,Houle D,et al. Pancreatic islet-specific expression of an insulin-like growth factor-i transgene compensates islet cell growth in growth hormone receptor gene-deficient mice[J]. Endocrinology,2005,146(6):2602-2609. doi: 10.1210/en.2004-1203
[13]	Klover P,Hennighausen L. Postnatal body growth is dependent on the transcription factors signal transducers and activators of transcription 5a/b in muscle:A role for autocrine/paracrine insulin-like growth factor I[J]. Endocrinology,2007,148(4):1489-1497. doi: 10.1210/en.2006-1431
[14]	Maedler K,Bonkowski M S,Dominici F P,et al. Disruption of growth hormone receptor prevents calorie restriction from improving insulin action and longevity[J]. PLoS ONE,2009,4(2):e4567. doi: 10.1371/journal.pone.0004567
[15]	Gaubitz C,Oliveira T M,Prouteau M,et al. Molecular basis of the rapamycin insensitivity of target of rapamycin complex 2[J]. Mol Cell,2015,58(6):977-988. doi: 10.1016/j.molcel.2015.04.031
[16]	Fang Y,Hill C M,Darcy J,et al. Effects of rapamycin on growth hormone receptor knockout mice[J]. Proc Natl Acad Sci U S A,2018,115(7):E1495-E1503. doi: 10.1073/pnas.1717065115
[17]	Sesti G,Federici M,Hribal M L,et al. Defects of the insulin receptor substrate(IRS)system in human metabolic disorders[J]. FASEB J,2001,15(12):2099-2111. doi: 10.1096/fj.01-0009rev
[18]	Gual P,Le Marchand-Brustel Y,Tanti J-F. Positive and negative regulation of insulin signaling through IRS-1phosphorylation[J]. Biochimie,2005,87(1):99-109. doi: 10.1016/j.biochi.2004.10.019
[19]	Smith T R,Elmendorf J S,David T S,et al. Growth hormone-induced insulin resistance role of the insulin receptor,IRS-I,GLUT-I and GLUT-4[J]. Am J Physiol,1997,272(6pt1):E1071-E1079.
[20]	Thirone A C,Carvalho C R,Brenelli S L,et al. Effect of chronic growth hormone treatment on insulin signal transduction in rat tissues[J]. Mol Cell Endocrinol,1997,130(1-2):33-42. doi: 10.1016/S0303-7207(97)00071-3
[21]	Robertson K,Kopchick J J,Liu J L. Growth hormone receptor gene deficiency causes delayed insulin responsiveness in skeletal muscles without affecting compensatory islet cell overgrowth in obese mice[J]. Am J Physiol Endocrinol Metab,2006,291(3):E491-E498. doi: 10.1152/ajpendo.00378.2005
[22]	Mavalli M D,DiGirolamo D J,Fan Y,et al. Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice[J]. J Clin Invest,2010,120(11):4007-4020. doi: 10.1172/JCI42447
[23]	Sasaki-Suzuki N,Arai K,Ogata T,et al. Growth hormone inhibition of glucose uptake in adipocytes occurs without affecting GLUT4 translocation through an insulin receptor substrate-2-phosphatidylinositol 3-kinase-dependent pathway[J]. J Biol Chem,2009,284(10):6061-6070. doi: 10.1074/jbc.M808282200
[24]	Dominici F P,Cifone D,Bartke A,et al. Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice[J]. Am J Physiol,1999,277(3):E447-E454.
[25]	Takano A,Haruta T,Iwata M,et al. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes[J]. Diabetes,2001,50(8):1891-1900. doi: 10.2337/diabetes.50.8.1891
[26]	Ueki K,Fruman D A,Yballe C M,et al. Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling[J]. J Biol Chem,2003,278(48):48453-48466. doi: 10.1074/jbc.M305602200
[27]	Del Rincon J P,Iida K,Gaylinn B D,et al. Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue:Mechanism for growth hormone-mediated insulin resistance[J]. Diabetes,2007,56(6):1638-1646. doi: 10.2337/db06-0299
[28]	Ueki K,Yballe C M,Brachmann S M,et al. Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase[J]. Proc Natl Acad Sci U S A,2002,99(1):419-424. doi: 10.1073/pnas.012581799
[29]	Mauvais-Jarvis F,Ueki K,Fruman D A,et al. Reduced expression of the murine p85αsubunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes[J]. J Clin Invest,2002,109(1):141-149. doi: 10.1172/JCI0213305
[30]	Taniguchi C M,Emanuelli B,Kahn CR. Critical nodes in signalling pathways:Insights into insulin action[J]. Nat Rev Mol Cell Biol,2006,7(2):85-96.
[31]	Yakar S,Setser J,Zhao H,et al. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice[J]. J Clin Invest,2004,113(1):96-105. doi: 10.1172/JCI200417763
[32]	Fruman D A,Mauvais-Jarvis F,Pollard D A,et al. Hypoglycaemia,liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha[J]. Nature Genetics,2000,26(3):379-382. doi: 10.1038/81715
[33]	Barbour L A,Mizanoor Rahman S,Gurevich I,et al. Increased P85α is a potent negative regulator of skeletal muscle insulin signaling and inducesin vivoinsulin resistance associated with growth hormone excess[J]. J Biol Chem,2005,280(45):37489-37494. doi: 10.1074/jbc.M506967200
[34]	Kohn A D,Summers S A,Birnbaum M J,et al. Expression of a constitutively active akt ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation[J]. J Biol Chem,1996,271(49):31372-31378. doi: 10.1074/jbc.271.49.31372
[35]	Haruta T,Morris A J,Rose D W,et al. Insulin-stimulated GLUT4 translocation is mediated by a divergent intracellular signaling pathway[J]. J Biol Chem,1995,270(47):27991-27994. doi: 10.1074/jbc.270.47.27991
[36]	Yokota I,Hayashi H,Matsuda J,et al. Effect of growth hormone on the translocation of GLUT4 and its relation to insulin-like and anti-insulin action[J]. Biochim Biophys Acta,1998,1404(3):451-456. doi: 10.1016/S0167-4889(98)00077-9
[37]	Dalmolin C,Almeida D V,Figueiredo M A,et al. Expression profile of glucose transport-related genes under chronic and acute exposure to growth hormone in zebrafish[J]. Comp Biochem Physiol A Mol Integr Physiol,2018,221(18):1-6.
[38]	Schwartz J,Carter-Su C. Effects of growth hormone on glucose metabolism and glucose transport in 3T3-F442A cells:Dependence on cell differentiation[J]. Endocrinology,1988,122(5):2247-2256. doi: 10.1210/endo-122-5-2247
[39]	Imamura H,Morimoto I,Etoh S,et al. Skeletal muscle glucose transporter gene expression is not affected by injecting growth-hormone-secreting cells in young rats[J]. Diabetologia,1993,36(6):475-480. doi: 10.1007/BF02743260
[40]	Cartee G D,Bohn E E. Growth hormone reduces glucose transport but not GLUT-l or GLUT-4 in adult and old rats[J]. Am J Physiol,1995,268(5Pt1):E902-E909.
[41]	Napoli R,Cittadini A,Chow J C,et al. Chronic growth hormone treatment in normal rats reduces postprandial skeletal muscle plasma membrane GLUT1 content,but not glucose transport or GLUT4 expression and localization[J]. Biochem J,1996,315(Pt3):959-963.
[42]	Morita J,Hakuno F,Hizuka N,et al. Growth hormone(GH) or insulin-like growth factor(IGF-1)represses 11β-Hydroxysteroid dehydrogenase type 1(HSD1)mRNA expression in 3T3-L1 cells and its activity in their homogenates[J]. Endocrine Journal,2009,56(4):561-570. doi: 10.1507/endocrj.K08E-311
[43]	Li R S,Nakagawa Y,Liu Y J,et al. Growth hormone inhibits the 11β-hydroxysteroid dehydrogenase type 1 gene promoter activity via insulin-like growth factor I in HepG2 cells[J]. Hormone and Metabolic Research,2008,40(4):286-288. doi: 10.1055/s-2008-1058076
[44]	Stewart P M,Toogood A A,Tomlinson J W. Growth hormone,insulin-like growth factor-I and the cortisol-cortisone shuttle[J]. Horm Res,2001,56(Suppl 1):1-6.
[45]	Chowdhury S,Grimm L,Gong Y J,et al. Decreased 11beta-hydroxysteroid dehydrogenase 1 level and activity in murine pancreatic islets caused by insulin-like growth factor I overexpression[J]. PLoS One,2015,10(8):e0136656. doi: 10.1371/journal.pone.0136656
[46]	Mondok A,Varga I,Glaz E,et al. 11beta-hydroxysteroid dehydrogenase activity in acromegalic patients with normal or impaired carbohydrate metabolism[J]. Steroids,2009,74(9):725-729. doi: 10.1016/j.steroids.2009.03.003

Relative Articles(20)

Relative Articles

[1]	Huijuan ZENG, Bo TIAN, Hongling YUAN, Jie HE, Guanxi LI, Guojia RU, Min XU, Dong ZHAN. Predictive Modeling of Chronic Kidney Disease with Hypertension or Diabetes Based on Machine Learning Algorithms. Journal of Kunming Medical University, 2024, 45(3): 99-105. doi: 10.12259/j.issn.2095-610X.S20240315
[2]	Yi MO, Huifang LI, Chunmei ZUO, Jinbo LI, Jingrong SHEN, Xia WU, Le CAI. Study on the Trends in Prevalence，Awareness，Treatment， and Control of Diabetes among NaXi Ethnic Minority in Yunnan Province. Journal of Kunming Medical University, 2022, 43(10): 16-21. doi: 10.12259/j.issn.2095-610X.S20221015
[3]	Xu ZHENG, Chen XIE, Rao FU, Yu-zhi WU, Zhu-ling GUO. A Survey on the Cognition of the Relationship between Periodontitis and Diabetes Mellitus in Type 2 Diabetes Patients and Endocrinologists. Journal of Kunming Medical University, 2021, 42(3): 89-93. doi: 10.12259/j.issn.2095-610X.S20210323
[4]	Yang Shu Di , Cai Le , Ma Guo Yu , Yang Jia Tian , Cui Wen Long . . Journal of Kunming Medical University, 2019, 40(04): 41-45.
[5]	Yu Shan , Wang Bo . 糖尿病健康教育研究进展. Journal of Kunming Medical University, 2018, 39(04): 130-134.
[6]	Huang Jing Jing , Yang Sheng Jie , Cui Wen Long , Li Xiao , Ma Zhi Xiang , Wu Chao , Cai Le . The Prevalence, Awareness, Treatment, Control and Self-management of Diabetes among the Elderly in Midu County. Journal of Kunming Medical University, 2018, 39(01): 45-49.
[7]	Chen Qian . . Journal of Kunming Medical University, 2017, 38(03): 71-74.
[8]	Yan Sui Jun, Li Hui Fang . . Journal of Kunming Medical University, 2017, 38(03): 1-5.
[9]	Zeng Xiao Yan , Wu Bin , Yang Hui Ying , Yang Chun Ai , Huang Yun Hua . . Journal of Kunming Medical University, 2017, 38(02): 82-85.
[10]	Chen Min . Correlation Research of RANTES and Its Receptor CCR5 with Diabetes. Journal of Kunming Medical University,
[11]	Wang Hong Xiong . . Journal of Kunming Medical University,
[12]	Dang Yan Yan . . Journal of Kunming Medical University,
[13]	Zhu Wei . . Journal of Kunming Medical University,
[14]	Peng Hui . . Journal of Kunming Medical University,
[15]	Xiong Yu Xin . . Journal of Kunming Medical University,
[16]	Qin Min Li . . Journal of Kunming Medical University,
[17]	Ao Lei . . Journal of Kunming Medical University,
[18]	Li Hui Fang . . Journal of Kunming Medical University,
[19]	. . Journal of Kunming Medical University,
[20]	Cheng Hui Rong . . Journal of Kunming Medical University,